Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goflikicept in Acute STEMI
NCT04463251Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of goflikicept in ST elevation myocardial infarction (STEMI), sponsored by R-Pharm. Started Dec 2020; status: completed.
02
Drugs
goflikicept
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04463251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463251.